Paclitaxel-coated balloons beat Taxus
This article was originally published in Clinica
Executive Summary
Paclitaxel-coated balloons are as effective a method of preventing restenosis as the use of paclitaxel-eluting stents such as Boston Scientific's Taxus. So claimed a trial presented at the Transcatheter Cardiovascular Therapeutics (TCT) meeting, held in Washington DC last week.